166 related articles for article (PubMed ID: 22027009)
21. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of mucins in the classification of ampullary carcinomas.
Paulsen FP; Varoga D; Paulsen AR; Corfield A; Tsokos M
Hum Pathol; 2006 Feb; 37(2):160-7. PubMed ID: 16426915
[TBL] [Abstract][Full Text] [Related]
23. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival.
Hsu HP; Shan YS; Lai MD; Lin PW
Cancer Biol Ther; 2010 Jul; 10(2):144-54. PubMed ID: 20495367
[TBL] [Abstract][Full Text] [Related]
24. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.
Alos L; Lujan B; Castillo M; Nadal A; Carreras M; Caballero M; de Bolos C; Cardesa A
Am J Surg Pathol; 2005 Jun; 29(6):806-13. PubMed ID: 15897748
[TBL] [Abstract][Full Text] [Related]
25. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
Zhou H; Schaefer N; Wolff M; Fischer HP
Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
[TBL] [Abstract][Full Text] [Related]
26. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
27. Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia.
Chen MC; Chen YL; Wang TW; Hsu HP; Lai MD
Oncol Rep; 2016 Oct; 36(4):1997-2008. PubMed ID: 27510297
[TBL] [Abstract][Full Text] [Related]
28. Nestin predicts a favorable prognosis in early ampullary adenocarcinoma and functions as a promoter of metastasis in advanced cancer.
Shan YS; Chen YL; Lai MD; Hsu HP
Oncol Rep; 2015 Jan; 33(1):40-8. PubMed ID: 25371063
[TBL] [Abstract][Full Text] [Related]
29. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
Sonoue H; Suda K; Nobukawa B; Abe H; Arakawa A; Hirai S; Matsumoto T
J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
[TBL] [Abstract][Full Text] [Related]
30. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
Sierzega M; Młynarski D; Tomaszewska R; Kulig J
Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
[TBL] [Abstract][Full Text] [Related]
31. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.
Gonzalez RS; Bagci P; Basturk O; Reid MD; Balci S; Knight JH; Kong SY; Memis B; Jang KT; Ohike N; Tajiri T; Bandyopadhyay S; Krasinskas AM; Kim GE; Cheng JD; Adsay NV
Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329
[TBL] [Abstract][Full Text] [Related]
32. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
33. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS
Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108
[TBL] [Abstract][Full Text] [Related]
34. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
[TBL] [Abstract][Full Text] [Related]
35. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
[TBL] [Abstract][Full Text] [Related]
37. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).
Buyuk M; Ozluk Y; Bakkaloglu DV; Ozkan B; Firat P; Yilmazbayhan D
Turk Patoloji Derg; 2023; 39(1):64-74. PubMed ID: 36367122
[TBL] [Abstract][Full Text] [Related]
39. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
40. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]